Prime Medicine Inc (PRME) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Prime Medicine Inc   (NASDAQ: PRME)


Prime Medicine Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Prime Medicine Inc 's ROA in the second quarter of 2026?
Prime Medicine Inc recorded a cumulative net loss of $-83 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -26.24%.

However, within the Healthcare sector 395 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3864, from total ROA ranking in the first quarter of 2026 at 4701.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -10.74 % -10.19 % 45.05 % 42.94 % 43.36 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -83 -146 -201 -546 -601
Return On Assets (TTM) -26.24 % -45.02 % -60.27 % -177.87 % -215.93 %
PRME's Total Ranking # 3864 # 4701 # 4558 # 4671 # 4692
Total Assets (TTM) in million 249 295 343 385 279
Seq. Total Assets Change -15.5 % -14.01 % -10.98 % 37.99 % -14.98 %
Seq. Net Income Change - - - - -

PRME's 5 Years Annual ROA >> Back to PRME Management Effectiveness >> Compare PRME ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 40
Sector # 396
Overall # 3536

Return On Assets Statistics
High Average Low
0.11 %
-63.17 %
-194.18 %
(Dec 31 2023)   (Jun 30 2025)



  News about Prime Medicine Inc Return on Assets ROA

Prime Medicine Charts a New Course in Genetic Medicine: Innovative Strategies and Strong Financial Performance Pave the Path Ahead,

Prime Medicine s Strategic Advancements in Genetic MedicinePrime Medicine Inc. is making waves in the biotechnology sector with its innovative approach to genetic medicine, capitalizing on its prime editing platform to establish a strategically focused pipeline. With an emphasis on high-value programs in core therapeutic areas, the company aims to set a strong foothold in the rapidly evolving landscape of genetic therapeutics. Key Developments in Prime MedicineIn a recent announcement, Prime Medicine unveiled its plan to prioritize a set of programs that are expected to deliver high returns on investment. The modularity of the Prime Editing Platform is a significant advantage, allowing the company to generate follow-on candidates both rapidly and efficiently. This flexibility is crucial in the fast-paced world of biotech, where the ability to pivot quickly in response to new data and opportunities can differentiate successful companies from their competitors.



Financial Statements
Prime Medicine Inc 's Assets $ 249 million PRME's Balance sheet
Prime Medicine Inc 's Income $ -42 million Quarterly PRME's Income Statement
PRME's Income by Division See PRME's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2020)
FY 2022
FY
Y / Y Total Assets Change 45.05 % 40.12 % -41.22 % - -
Total Assets in million 343 236 169 287 0
Y / Y Net Income Change - - - - -
Net Income in million -201 -392 0 -3 0
Annual Return On Assets -58.69 % -165.8 % 0.17 % -1.19 % -

PRME's 5 Years Annual ROA >> Back to PRME Management Effectiveness >> Compare PRME ROA to its Competitors



More Return On Assets Ratios
PRME's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRME's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRME's Competitors
Subscribers only: Roa for Prime Medicine Inc 's Suppliers
Subscribers only: Return On Assets for PRME's Customers

You may also want to know
PRME's Roi PRME's Inventory Turnover Ratio PRME's Growth Rates PRME's Dividend Comparisons
PRME's Profitability Ratios PRME's Asset Turnover Ratio PRME's Dividend Growth
PRME's Roe PRME's Valuation Ratios PRME's Financial Strength Ratios PRME's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T21:43:37+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.